Masimo (MASI) Cash & Equivalents (2009 - 2026)
Masimo's (MASI) quarterly Cash & Equivalents came in at $124.6 million in Q2 2026, up 202.43% year-on-year from $41.2 million in Q2 2025, and down 18.19% quarter-over-quarter from $152.3 million in Q1 2026.
Masimo (MASI) Cash & Equivalents (2009 - 2026) Analysis & Trends
Masimo's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $124.6 million for Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 202.43% year-over-year to $124.6 million in Q2 2026; TTM through Apr 2026 was $124.6 million, a 202.43% increase from a year earlier, with the FY2026 full-year figure at $152.3 million, up 23.22% from the prior year.
- Cash & Equivalents eased to $124.6 million in Q2 2026 per MASI's latest filing, from $152.3 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $745.3 million in Q1 2022 and bottomed at $36.4 million in Q2 2024.
- The 5-year median for Cash & Equivalents is $150.2 million (2023), against an average of $213.9 million.
- Across the five-year window, Cash & Equivalents plunged 75.85% in 2024 and soared 310.99% in 2025, its largest moves.
- Year by year, Cash & Equivalents stood at $202.9 million in 2022, then slumped by 40.46% to $120.8 million in 2023, then increased by 2.32% to $123.6 million in 2024, then surged by 152.67% to $312.3 million in 2025, then tumbled by 60.1% to $124.6 million in 2026.
- Per Business Quant, the three latest MASI Cash & Equivalents figures stand at $124.6 million (Q2 2026), $152.3 million (Q1 2026), and $312.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 124.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 124.60 Mn |
| Jan 3, 2026 | 152.30 Mn |
| Sep 27, 2025 | 312.30 Mn |
| Jun 28, 2025 | 149.60 Mn |
| Mar 29, 2025 | 41.20 Mn |
| Dec 28, 2024 | 123.60 Mn |
| Sep 28, 2024 | 117.00 Mn |
| Jun 29, 2024 | 36.40 Mn |
| Mar 30, 2024 | 118.10 Mn |
| Dec 30, 2023 | 120.80 Mn |
| Sep 30, 2023 | 124.40 Mn |
| Jul 1, 2023 | 150.70 Mn |
| Apr 1, 2023 | 174.10 Mn |
| Dec 31, 2022 | 202.90 Mn |
| Oct 1, 2022 | 219.50 Mn |
| Jul 2, 2022 | 218.00 Mn |
| Apr 2, 2022 | 720.00 Mn |
| Jan 1, 2022 | 745.30 Mn |
| Oct 2, 2021 | 652.30 Mn |
| Jul 3, 2021 | 576.00 Mn |